Amy E. Juedes

Array ( [id] => 11678315 [patent_doc_number] => 09676832 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-13 [patent_title] => 'Dendritic cell inhibitory proteins from ticks' [patent_app_type] => utility [patent_app_number] => 13/636469 [patent_app_country] => US [patent_app_date] => 2011-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 21428 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13636469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697156 [patent_doc_number] => 20110229434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'USES OF MAMMALIAN CYTOKINE; RELATED REAGENTS' [patent_app_type] => utility [patent_app_number] => 13/052404 [patent_app_country] => US [patent_app_date] => 2011-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12834 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229434.pdf [firstpage_image] =>[orig_patent_app_number] => 13052404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8927583 [patent_doc_number] => 20130183343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'System and Method of Preparing and Storing Activated Mature Dendritic Cells' [patent_app_type] => utility [patent_app_number] => 13/635075 [patent_app_country] => US [patent_app_date] => 2011-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17545 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8606124 [patent_doc_number] => 20130011436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'Methods and Compositions Containing Fc Fusion Proteins for Enhancing Immune Responses' [patent_app_type] => utility [patent_app_number] => 13/577990 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14162 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8659482 [patent_doc_number] => 20130040311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERP29 AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/583312 [patent_app_country] => US [patent_app_date] => 2011-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11671 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13583312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8950139 [patent_doc_number] => 20130195919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'INDUCED DENDRITIC CELL COMPOSITIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/582897 [patent_app_country] => US [patent_app_date] => 2011-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 40520 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697104 [patent_doc_number] => 20110229486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'Monoclonal Antibodies Against NKG2A' [patent_app_type] => utility [patent_app_number] => 13/036240 [patent_app_country] => US [patent_app_date] => 2011-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 36899 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229486.pdf [firstpage_image] =>[orig_patent_app_number] => 13036240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8696948 [patent_doc_number] => 20130058957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'DENDRITIC CELL IMMUNORECEPTOR AGONIST' [patent_app_type] => utility [patent_app_number] => 13/580689 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11542 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13580689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9989120 [patent_doc_number] => 09034317 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-19 [patent_title] => 'Composition for inhibiting tumor cell proliferation' [patent_app_type] => utility [patent_app_number] => 13/522741 [patent_app_country] => US [patent_app_date] => 2011-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 9456 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13522741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212384 [patent_doc_number] => 20110135684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes in mature dendritic cells in vitro' [patent_app_type] => utility [patent_app_number] => 12/929701 [patent_app_country] => US [patent_app_date] => 2011-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8615 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135684.pdf [firstpage_image] =>[orig_patent_app_number] => 12929701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14731461 [patent_doc_number] => 10385120 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-20 [patent_title] => Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination [patent_app_type] => utility [patent_app_number] => 13/576083 [patent_app_country] => US [patent_app_date] => 2011-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19965 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13576083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110339 [patent_doc_number] => 20110189200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'METHODS OF TREATING AUTOIMMUNE DISEASES WITH DLL4 ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/015637 [patent_app_country] => US [patent_app_date] => 2011-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 14077 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189200.pdf [firstpage_image] =>[orig_patent_app_number] => 13015637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8684358 [patent_doc_number] => 20130052642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'METHOD FOR THE IDENTIFICATION AND PURIFICATION OF HUMAN NATURALLY OCCURRING REGULATORY T CELLS (NTREGS)' [patent_app_type] => utility [patent_app_number] => 13/575247 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19420 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733323 [patent_doc_number] => 20120015890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'Use of Soluble Forms of CD83 and Nucleic Acids Encoding them for the Treatment or Prevention of Diseases' [patent_app_type] => utility [patent_app_number] => 13/011380 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 15404 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015890.pdf [firstpage_image] =>[orig_patent_app_number] => 13011380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174442 [patent_doc_number] => 20110177107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'PREDICTING AND REDUCING ALLOIMMUNOGENICITY OF PROTEIN THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 13/007403 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24364 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177107.pdf [firstpage_image] =>[orig_patent_app_number] => 13007403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6188791 [patent_doc_number] => 20110171664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'METHODS AND REAGENTS FOR DETECTING SUSCEPTIBILITY TO GRAFT VERSUS HOST DISEASE OR TRANSPLANT RELATED MORTALITY' [patent_app_type] => utility [patent_app_number] => 13/004610 [patent_app_country] => US [patent_app_date] => 2011-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9275 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171664.pdf [firstpage_image] =>[orig_patent_app_number] => 13004610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958534 [patent_doc_number] => 20110182921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/981098 [patent_app_country] => US [patent_app_date] => 2010-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 23362 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182921.pdf [firstpage_image] =>[orig_patent_app_number] => 12981098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7711719 [patent_doc_number] => 20120004124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'MARKERS OF REGULATORY T CELL ACTIVATION' [patent_app_type] => utility [patent_app_number] => 12/972954 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16203 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12972954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080226 [patent_doc_number] => 20110142887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Methods and compositions for liquidation of tumors' [patent_app_type] => utility [patent_app_number] => 12/967910 [patent_app_country] => US [patent_app_date] => 2010-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6756 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142887.pdf [firstpage_image] =>[orig_patent_app_number] => 12967910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501521 [patent_doc_number] => 20110263517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Cytokines and Cytokine Receptors with Reduced Immunogenicity' [patent_app_type] => utility [patent_app_number] => 12/958139 [patent_app_country] => US [patent_app_date] => 2010-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15380 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263517.pdf [firstpage_image] =>[orig_patent_app_number] => 12958139 [rel_patent_id] =>[rel_patent_doc_number] =>)